Letter by Niccoli et al regarding article, "intracoronary versus intravenous administration of abciximab in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of st-segment elevation myocardial infarction (CICERO) trial"

Circulation. 2011 Aug 23;124(8):e230; author reply e231. doi: 10.1161/CIRCULATIONAHA.110.011262.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angioplasty, Balloon, Coronary / methods*
  • Antibodies, Monoclonal / therapeutic use*
  • Anticoagulants / therapeutic use*
  • Electrocardiography*
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Male
  • Myocardial Infarction / therapy*
  • Myocardial Reperfusion Injury / prevention & control*
  • Thrombosis / therapy*

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments